NCT04792892 ANCA II - Quality of Life and Functional Outcome in Patients With Anal Cancer
| NCT ID | NCT04792892 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sahlgrenska University Hospital |
| Condition | Anal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 600 participants |
| Start Date | 2021-08-01 |
| Primary Completion | 2025-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 600 participants in total. It began in 2021-08-01 with a primary completion date of 2025-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Anal cancer is a rare disease, but the incidence is rising. About 200 patients will get this type of cancer yearly in Sweden. Curative treatment includes chemotherapy and radiotherapy. The prognosis is good, but some patients will have recurrent or persistent disease after concluded chemo-radiotherapy and will then be offered salvage surgery. Some patients develop distant metastases that can be treated with good results. The aim of this study is to identify and describe functional outcome in patients diagnosed with anal cancer. We will study patients from diagnosis, try to identify early toxicity to treatment and then identify long-term morbidity.
Eligibility Criteria
Inclusion Criteria: * Age \> 18 years * Anal squamous carcinoma diagnosed within the last 2 months Exclusion Criteria: -No informed consent
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04792892 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Anal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04792892 currently recruiting?
Yes, NCT04792892 is actively recruiting participants. Contact the research team at eva.angenete@vgregion.se for enrollment information.
Where is the NCT04792892 trial being conducted?
This trial is being conducted at Gothenburg, Sweden.
Who is sponsoring the NCT04792892 clinical trial?
NCT04792892 is sponsored by Sahlgrenska University Hospital. The trial plans to enroll 600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.